ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,629.00
0.55%
S&P ASX All Technology
3,016.30
1.48%
Brent Oil
82.765
0.00%
US Dollar vs AUD
1.514
-0.05%
Bitcoin
63,892.52
0.00%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Angion Biomedica Corporation (ANGN)

  7. Angion Biomedica Corporation (ANGN) News

ANGN

Angion Biomedica (ANGN)

Angion Biomedica Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ANGN
DateTimeSourceHeadlineSymbolCompany
29/04/202421:00Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:ANGNAngion Biomedica Corporation
06/04/202407:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
30/03/202406:28Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ANGNAngion Biomedica Corporation
30/03/202406:26Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ANGNAngion Biomedica Corporation
30/03/202404:58Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ANGNAngion Biomedica Corporation
29/03/202423:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
21/03/202407:37Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ANGNAngion Biomedica Corporation
21/03/202407:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGNAngion Biomedica Corporation
18/03/202423:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
05/02/202422:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGNAngion Biomedica Corporation
05/02/202422:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGNAngion Biomedica Corporation
05/02/202422:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGNAngion Biomedica Corporation
05/02/202422:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGNAngion Biomedica Corporation
03/02/202400:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
18/01/202400:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
16/01/202423:59Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
10/01/202400:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
06/01/202408:05Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ANGNAngion Biomedica Corporation
30/12/202309:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGNAngion Biomedica Corporation
30/12/202309:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGNAngion Biomedica Corporation
27/12/202308:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGNAngion Biomedica Corporation
27/12/202308:25Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ANGNAngion Biomedica Corporation
23/12/202301:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
14/11/202300:45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANGNAngion Biomedica Corporation
10/11/202308:41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
04/11/202308:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
20/10/202322:58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
12/10/202322:59Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
07/09/202322:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
31/08/202306:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
 Showing the most relevant articles for your search:NASDAQ:ANGN

Your Recent History

FX
AUDCAD
AUD vs CAD
ASX
WOW
Woolworths
ASX
AMP
AMP
ASX
CBA
Commonwealth Bank Of Aus...
NASDAQ
QQQ
Invesco QQQ Trust Series 1
ASX
XMM
S&P ASX 300 Metals and M...
ASX
XAO
Australian SE All Ordina...
CCOM
SILVER
SILVER
ASX
WBC
Westpac Banking
FX
GBPAUD
Sterling vs AUD
ASX
XJO
S&P ASX 200
FX
AUDJPY
AUD vs Yen
NASDAQ
AAPL
Apple
ASX
QBE
QBE Insurance
ASX
NAB
National Australia Bank
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved